Encefalitis límbica autoinmune

Brierley, 1960, Subacute encephalitis of later adult life mainly affecting the limbic areas, Brain., 83, 357, 10.1093/brain/83.3.357 Corsellis, 1968, “Limbic encephalitis” and its association with carcinoma, Brain., 91, 481, 10.1093/brain/91.3.481 Abel, 2001, Estado epiléptico parcial no convulsivo como síntoma de presentación de encefalitis límbica, Neurol Arg., 32, 734 Ramos-Rivas, 2009, Encefalitis límbica paraneoplásica: una entidad de difícil diagnóstico, Neurol Arg., 48, 311 PratsViñas, 2003, Encefalitis límbica no paraneoplásica, Rev Neurol., 36, 335 Machado, 2012, What should you know about limbic encephalitis?, Arq Neuropsiquiatr., 70, 817, 10.1590/S0004-282X2012001000012 Irani, 2011, Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis, Ann Neurol., 69, 892, 10.1002/ana.22307 Grisold, 2011, Current approaches to the treatment of paraneoplastic encephalitis, Ther Adv Neurol Disord., 4, 237, 10.1177/1756285611405395 Darnell, 2003, Paraneoplastic syndromes involving the nervous system, N Engl J Med., 349, 1543, 10.1056/NEJMra023009 Shimazaki, 2007, Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus, J Neurol Neurosurg Psychiatry., 78, 324, 10.1136/jnnp.2006.104513 Graus, 2004, Recommended diagnostic criteria for paraneoplastic neurological syndromes, J Neurol Neurosurg Psychiatry., 75, 1135, 10.1136/jnnp.2003.034447 Dalmau, 2004, Clinical analysis of anti-Ma2-associated encephalitis, Brain., 127, 1831, 10.1093/brain/awh203 Compta, 2007, REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis, Sleep., 30, 767, 10.1093/sleep/30.6.767 Vincent, 2011, Autoantibodies associated with diseases of the CNS: new developments and future challenges, Lancet., 10, 759, 10.1016/S1474-4422(11)70096-5 Irani, 2010, Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia, Brain., 133, 2734, 10.1093/brain/awq213 Lai, 2010, Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: A case series, Lancet Neurol., 9, 776, 10.1016/S1474-4422(10)70137-X Saccardi, 2011, Subacute cognitive impairment, hyponatremia and mesial temporal lobe lesions. A typical presentation of voltage-gated potassium channel (VGKC) antibody-associated limbic encephalitis, Arq Neuropsiquiat., 96, 990, 10.1590/S0004-282X2011000700028 Bataller, 2007, Autoimmune limbic encephalitis in 39 patients: Immunophenotypes and outcomes, J Neurol Neurosurg Psychiatry., 78, 381, 10.1136/jnnp.2006.100644 Rey, 2012, Striatal hypermetabolism in limbic encephalitis, J Neurol., 259, 1106, 10.1007/s00415-011-6308-2 Toledano, 2014, Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy, Neurology., 82, 1578, 10.1212/WNL.0000000000000383 Irani, 2013, Faciobrachial dystonic seizures: The influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype, Brain., 136, 3151, 10.1093/brain/awt212 Vincent, 2004, Potassium channel antibody-associated encephalopathy: A potentially immunotherapyresponsive form of limbic encephalitis, Brain., 127, 701, 10.1093/brain/awh077